Contact Us

Product Development - Pharmaceuticals

In the ever-changing pharmaceutical market, new drug delivery and formulation technologies such as inhalants, transdermal patches, auto injectors, extended release, suspensions and companion diagnostics continue to drive innovation.

Many companies are tasked with introducing bio-similars and generics, and all are challenged to develop differentiated drugs with less R&D spend.

Filling a company’s early-stage pipeline only accounts for part of the challenge. Pharmaceutical companies must navigate today’s complex regulatory and strict commercialization environments as healthcare payers impose new cost constraints and carefully scrutinize the value medicines offer.

Integrated Project Management Company, Inc.’s (IPM) project management consultants expertly address challenges across the pharmaceutical product development process, turning the most complex situations into manageable strategies and plans. By employing an engaged, hands-on approach, we execute your initiatives and lead your teams so that you reach your goals on time and on budget. We impart the knowledge and best practices gained from years of experience working with some of the largest drug manufacturers in the industry.

If you have a vision for your organization or functional area, IPM can help you make it a reality.

Featured Articles

New Drug Commercialization

A Project Leadership Perspective on Approaching Market Access A new drug product launch is an exciting time for a pharmaceutical company. New product development is…

Read Article

Tighter Research Processes Lead to $10 Million in New Funding for Biotech Start-Up

Project Background A start-up nanotechnology company needed to raise additional funding to continue development of its holographic optical trapping (HOT) technology. To capture investor attention,…

Read Article

Professional Plan and Execution Results in On-Time IND Submission and Clinical Program Initiation

Project Background A mid-size biotechnology company with multiple development candidates in their pipeline lacked an overarching strategy for moving a lead compound from selection to…

Read Article

Fledgling Biotech Speeds towards NDA Due to Intense Coordination Effort

Project Background A privately held, startup biopharmaceutical company had acquired a key compound for treating cancer, one of a new class of anti-cancer agents. The…

Read Article